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 A STUDY ON THE THERAPEUTIC RESPONSE OF VITILIGO TO A 
COMBINATION OF NARROWBAND UVB AND ORAL MINIPULSE 
STEROID THERAPY 
ABSTRACT 
Introduction: Vitiligo is a common acquired depigmentation disorder resulting from the 
progressive loss of melanocytes. Although several modalities of treatment are available, 
therapy still remains difficult  and challenging. 
Aim: To evaluate the clinical response of vitiligo to combination therapy of narrow band UVB 
and oral minipulse steroid.   
Method: 100 patients with progressive and active vitiligo involving >20% BSA were given a 
combination therapy of narrowband UVB and oral minipulse steroid for 6 months followed by 
narrowband UVB alone for another 3 months and followed up till 12 months. Response to 
therapy was measured using VASI score. 
Results: Vitiligo was more common in women and in the age group of 26- 35 years. Almost half 
of the patients in our study had duration of illness between 1-5 years. Presence of leukotrichia, 
mucosal involvement, koebnerisation and a positive family history was associated with poorer 
response to therapy. The most common type of repigmentation seen was perifollicular. 61% of 
our patients showed minimal improvement, 36 % improved and 3% showed much improvement. 
Response to therapy was better in patients with good compliance. 
Conclusion:  Combination therapy of narrowband UVB and oral minipulse steroid can be an 
effective treatment option in patients with progressive vitiligo resulting in earlier repigmentation 
and with better colour matching. 
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